IRD — Opus Genetics, Inc. · rev $2.9M

Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.

Latest reported IRD revenue for 2026-06-30 was $2.9M. Net income was -$73.6M. Revenue was up 35.0% from 2026-03-31 to 2026-06-30. IRD currently screens at market cap $35.7M.

Use this IRD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IRD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IRD SEC filings page. Lician reads the product cache first so this HTML stays unique to Opus Genetics, Inc. even when a live quote feed is slow.